Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-18-008133
Filing Date
2018-04-30
Accepted
2018-04-30 15:49:41
Documents
5
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dffn20180430_defa14a.htm DEFA14A 19013
2 notice4.jpg GRAPHIC 59376
3 notice3.jpg GRAPHIC 68667
4 notice2.jpg GRAPHIC 143068
5 notice1.jpg GRAPHIC 126058
  Complete submission text file 0001437749-18-008133.txt   567595
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37942 | Film No.: 18789426
SIC: 2834 Pharmaceutical Preparations